:::

詳目顯示

回上一頁
題名:服用雞尾酒療法之愛滋病毒感染者其慢性病盛行率與發生率之探討
書刊名:臺灣公共衛生雜誌
作者:林咏臻楊靖慧黃彥芳賴安琪
作者(外文):Lin, Yung-jenYang, Chin-huiHuang, Yen-fangLai, An-chi
出版日期:2011
卷期:30:6
頁次:頁549-557
主題關鍵詞:人類免疫缺乏病毒雞尾酒療法糖尿病高血壓高血脂HIVHighly active antiretroviral therapyDiabetesHypertensionHyperlipidemia
原始連結:連回原系統網址new window
相關次數:
  • 被引用次數被引用次數:期刊(0) 博士論文(0) 專書(0) 專書論文(0)
  • 排除自我引用排除自我引用:0
  • 共同引用共同引用:0
  • 點閱點閱:51
期刊論文
1.Fang, C. T.、Chang, Y. Y.、Hsu, H. M.、Twu, S. J.、Chen, K. T.、Lin, C. C.(2007)。Life expectancy of patients with newly-diagnosed HIV infection in the era of highly active antiretroviral therapy。An International Journal of Medicine,100(2),97-105。  new window
2.Fang, Chi Tai、Chang, Yu Yin、Hsu, Hsu Mei、Twu, Shiing Jer、Chen, Kow Tong、Chen, Mao Yuan、Huang, Loreen Y. L.、Hwang, Jing Shiang、Wang, Jung Der(20070800)。Cost-effectiveness of Highly Active Antiretroviral Therapy for HIV Infection in Taiwan。Journal of the Formosan Medical Association,106(8),631-640。  new window
3.Lohse, N.、Hansen, A. B.、Pedersen, G.、Kronborg, G.、Gerstoft, J.、Sørensen, H. T.、Vaeth, M.、Obel, N.(2007)。Survival of persons with and without HIV infection in Denmark, 1995-2005。Annals of Internal Medicine,146(2),87-95。  new window
4.Kitahata, MM.、Gange, SJ.、Abraham, AG. et al.(20090430)。Effect of early versus deferred antiretroviral therapy for HIV on survival。N Engl J Med,360(18),1815-1826。  new window
5.Attia S, Egger M.、Müller, M.、Zwahlen, M.、Low N.(2009)。Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis。AIDS,23,1397-1404。  new window
6.Brown, TT.、Cole, SR.、Li, X. et al.(2005)。Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study。Arch Intern Med,165,1179-1184。  new window
7.Palacios, R.、Santos, J.、García, A. et al.(2006)。Impact of highly active antiretroviral therapy on blood pressure in HIV-infected patients. A prospective study in a cohort of naive patients。HIV Med,7,10-15。  new window
8.Crane, HM.、Van Rompaey, SE.、Kitahata, MM.(2006)。Kitahata MM. Antiretroviral medications associated with elevated blood pressure among patients receiving highly active antiretroviral therapy。AIDS,20,1019-1026。  new window
9.Wilson, SL.、Fidler, SJ.、Weber, JN.、Poulter, NR.(2009)。Effects of HIV status and antiretroviral therapy on blood pressure。HIV Med,10,388-394。  new window
10.Law, M.、Friis-Møller, N.、El-Sadr, W. et al.(2006)。The use of the Framingham equation to predict myocardial infarctions in HIV-infected patients: comparison with observed events in the D:A:D Study。HIV Med,7,218-230。  new window
11.Stein JH.(2005)。Managing cardiovascular risk in patients with HIV infection。J Acquir Immune Defic Syndr,38,115-123。  new window
12.Caron-Debarle, M.、Lagathu, C.、Boccara, F.、Vigouroux, C.、Capeau J.(2010)。HIV-associated lipodystrophy: from fat injury to premature aging。Trends Mol Med,16,218-229。  new window
13.Flint, OP.、Noor, MA.、Hruz, PW. et al.(2009)。The role of protease inhibitors in the pathogenesis of HIV-associated lipodystrophy: cellular mechanisms and clinical implications。Toxicol Pathol,37,65-77。  new window
14.Gkrania-Klotsas, E.、Klotsas, AE.(2007)。HIV and HIV treatment: effects on fats, glucose and lipids。Br Med Bull,84,49-68。  new window
15.Villarroya F,、Domingo, P.、Giralt, M.(2010)。Drug-induced lipotoxicity: lipodystrophy associated with HIV-1 infection and antiretroviral treatment。Biochim Biophys Acta,1801,392-399。  new window
16.Wit, SD.、Sabin, CA.、Weber, R. et al.(2008)。Incidence and risk factors for new-onset diabetes in HIV-infected patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study。Diabetes Care,31,1224-1229。  new window
17.Ledergerber, B.、Furrer, H.、Rickenbach, M. et al.(2007)。Factors associated with the incidence of Type 2 diabetes mellitus in HIV-infected participants in the Swiss HIV Cohort Study。Clin Infect Dis,45,111-119。  new window
18.Bergersen, BM.、Sandvik, L.、Dunlop, O.、Birkeland, K.、Bruun, JN.(2003)。Prevalence of hypertension in HIV-positive patients on highly active retroviral therapy (HAART) compared with HAART-naive and HIV-negative controls: results from a Norwegian study of 721 patients。Eur J Clin Microbiol Infect Dis,22,731-736。  new window
19.Friis-Møller, N.、Weber, R.、Reiss, P. et al.(2003)。Cardiovascular disease risk factors in HIV patients-association with antiretroviral therapy. Results from the DAD study。AIDS,17,1179-1193。  new window
20.Thiébaut, R.、Dequae-Merchadou, L.、Ekouevi, DK. et al.(2001)。Incidence and risk factors of severe hypertriglyceridemia in the era of highly active antiretroviral therapy: the Aquitaine Cohort, France, 1996–1999。HIV Med,2,84-88。  new window
其他
1.行政院衛生署國民健康局(2007)。2007年台灣地區高血壓、高血糖、高血脂之追蹤調查研究,http:// www.bhp.doh.gov.tw/BHPNet/Web/HealthTopic/TopicArticle.aspx?id=201102140001&parentid=2007 12250011, 2012/06/13。  延伸查詢new window
2.Bartlett, JG.,Braun, JE.,Sanne, IM.。Managing metabolic abnormalities in patients on A.R.T.,http://www.medscape.org/viewprogram/4748, 2011/05/30。  new window
 
 
 
 
第一頁 上一頁 下一頁 最後一頁 top